{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:33:36Z","timestamp":1789605216543,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To assess the histological correlate of neovascular or exudative myopic macular degeneration (nMMD) in highly myopic human eyes, we examined histomorphometrically histologic sections of enucleated eyes of Caucasian patients. The study included 284 eyes (age: 61.9\u2009\u00b1\u200913.7\u00a0years; range: 24\u201389\u00a0years; axial length: 25.5\u2009\u00b1\u20093.1\u00a0mm; range: 20\u201337\u00a0mm). An nMMD was detected in 5 eyes (axial length: 29.6\u2009\u00b1\u20092.6\u00a0mm; range: 26.0\u201331.0\u00a0mm). All these eyes showed within or close to the nMMD a macular Bruch\u2019s membrane (BM) defect, fibrous tissue with erythrocyte-filled blood vessels, and proliferations of irregularly pigmented and irregularly piled-up retinal pigment epithelium (RPE) cells each of which was connected with a curled-up, PAS (Periodic-Acid-Shiff)-positive membrane. The nMMD lesions were covered by proliferated RPE cells. RPE cells were not detected within the retina. In binary regression analysis, a higher nMMD prevalence was associated with a higher prevalence of macular BM defects (odds ratio:\u2009&gt;\u20091000; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), while the association with axial length was not significant (<jats:italic>P<\/jats:italic>\u2009=\u20090.43) in that model. After adjustment for the presence of macular BM defects, the nMMD prevalence was not associated with BM thickness (measured at the posterior pole, equator-posterior pole midpoint, equator and shortly posterior to the ora serrata) (<jats:italic>P<\/jats:italic>\u2009=\u20090.10; <jats:italic>P<\/jats:italic>\u2009=\u20090.87; <jats:italic>P<\/jats:italic>\u2009=\u20090.40; and <jats:italic>P<\/jats:italic>\u2009=\u20090.36, respectively), RPE cell layer thickness (<jats:italic>P<\/jats:italic>\u2009=\u20090.83; <jats:italic>P<\/jats:italic>\u2009=\u20090.79; <jats:italic>P<\/jats:italic>\u2009=\u20090.31; <jats:italic>P<\/jats:italic>\u2009=\u20090.38, resp.), RPE cell density (<jats:italic>P<\/jats:italic>\u2009=\u20090.56; <jats:italic>P<\/jats:italic>\u2009=\u20090.91; <jats:italic>P<\/jats:italic>\u2009=\u20090.47; <jats:italic>P<\/jats:italic>\u2009=\u20090.87, resp.), choriocapillaris thickness (<jats:italic>P<\/jats:italic>\u2009=\u20090.47; <jats:italic>P<\/jats:italic>\u2009=\u20090.93; <jats:italic>P<\/jats:italic>\u2009=\u20090.41; <jats:italic>P<\/jats:italic>\u2009=\u20090.75, resp.), and choriocapillaris density (<jats:italic>P<\/jats:italic>\u2009=\u20090.99; <jats:italic>P<\/jats:italic>\u2009=\u20090.94; <jats:italic>P<\/jats:italic>\u2009=\u20090.17; <jats:italic>P<\/jats:italic>\u2009=\u20090.97, resp.). The results suggest that nMMD is characterized by a fibrous pseudo-metaplasia of the RPE and is strongly associated with macular BM defects, without other detected histomorphometric differences in thickness or density of the RPE, BM, and choriocapillaris.<\/jats:p>","DOI":"10.1038\/s41598-021-01500-2","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T11:02:38Z","timestamp":1636455758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Histology of neovascular myopic macular degeneration"],"prefix":"10.1038","volume":"11","author":[{"given":"Shefali B.","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhomitra","family":"Panda-Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul A.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"1500_CR1","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ophtha.2009.11.003","volume":"117","author":"K Hayashi","year":"2010","unstructured":"Hayashi, K. et al. Long-term pattern of progression of myopic maculopathy: A natural history study. Ophthalmology 117, 1595\u20131611 (2010).","journal-title":"Ophthalmology"},{"key":"1500_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","volume":"121","author":"S Wolf","year":"2014","unstructured":"Wolf, S. et al. RADIANCE: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 121, 682\u2013692 (2014).","journal-title":"Ophthalmology"},{"key":"1500_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajo.2008.07.017","volume":"147","author":"Y Ikuno","year":"2009","unstructured":"Ikuno, Y. et al. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: One-year results. Am. J. Ophthalmol. 147, 94\u2013100 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"1500_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2017.12.005","volume":"125","author":"Y Fang","year":"2018","unstructured":"Fang, Y. et al. Progression of myopic maculopathy during 18-year follow-up. Ophthalmology 125, 863\u2013877 (2018).","journal-title":"Ophthalmology"},{"key":"1500_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.ophtha.2018.01.035","volume":"125","author":"YN Yan","year":"2018","unstructured":"Yan, Y. N. et al. Ten-year progression of myopic maculopathy: The Beijing Eye Study 2001\u20132011. Ophthalmology 125, 1253\u20131263 (2018).","journal-title":"Ophthalmology"},{"key":"1500_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00417-012-2066-9","volume":"251","author":"N Saka","year":"2013","unstructured":"Saka, N. et al. Changes of axial length measured by IOL master during 2 years in eyes of adults with pathologic myopia. Graefes Arch. Clin. Exp. Ophthalmol. 251, 495\u2013499 (2013).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"1500_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/bjophthalmol-2019-314619","volume":"104","author":"MW Lee","year":"2020","unstructured":"Lee, M. W., Lee, S. E., Lim, H. B. & Kim, J. Y. Longitudinal changes in axial length in high myopia: A 4-year prospective study. Br. J. Ophthalmol. 104, 600\u2013603 (2020).","journal-title":"Br. J. Ophthalmol."},{"key":"1500_CR8","doi-asserted-by":"publisher","first-page":"e0178998","DOI":"10.1371\/journal.pone.0178998","volume":"12","author":"Y Fang","year":"2017","unstructured":"Fang, Y. et al. Macular Bruch\u2019s membrane defect and dome-shaped macula in high myopia. PLoS ONE 12, e0178998 (2017).","journal-title":"PLoS ONE"},{"key":"1500_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/01.APO.0000578944.25956.8b","volume":"8","author":"JB Jonas","year":"2019","unstructured":"Jonas, J. B., Ohno-Matsui, K. & Panda-Jonas, S. Myopia: Anatomic changes and consequences for its etiology. Asia Pac. J. Ophthalmol. (Phila) 8, 355\u2013359 (2019).","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"key":"1500_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/IAE.0000000000002395","volume":"40","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Ridge-shaped macula in young myopic patients and its differentiation from typical dome-shaped macula in elderly myopic patients. Retina 40, 225\u2013232 (2020).","journal-title":"Retina"},{"key":"1500_CR11","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.preteyeres.2020.100933","volume":"83","author":"YX Wang","year":"2021","unstructured":"Wang, Y. X., Panda-Jonas, S. & Jonas, J. B. Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features. Prog. Retin. Eye Res. 83, 100933 (2021).","journal-title":"Prog. Retin. Eye Res."},{"key":"1500_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006982-199212020-00009","volume":"12","author":"HE Grossniklaus","year":"1992","unstructured":"Grossniklaus, H. E. & Green, W. R. Pathologic findings in pathologic myopia. Retina 12, 127\u2013133 (1992).","journal-title":"Retina"},{"key":"1500_CR13","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1111\/aos.14153","volume":"98","author":"RA Jonas","year":"2020","unstructured":"Jonas, R. A. & Holbach, L. Peripapillary border tissue of the choroid and peripapillary scleral flange in human eyes. Acta Ophthalmol. 98, e43\u2013e49 (2020).","journal-title":"Acta Ophthalmol."},{"key":"1500_CR14","first-page":"e856","volume":"98","author":"JB Jonas","year":"2020","unstructured":"Jonas, J. B., Ohno-Matsui, K., Holbach, L. & Panda-Jonas, S. Histology of myopic posterior scleral staphylomas. Acta Ophthalmol. 98, e856\u2013e863 (2020).","journal-title":"Acta Ophthalmol."},{"key":"1500_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00417-002-0563-y","volume":"240","author":"CW Spraul","year":"2002","unstructured":"Spraul, C. W., Jakobczyk-Zmija, M. J., Aigner, T. & Lang, G. K. Posterior fibrous pseudometaplasia of lens epithelial cells in phacic eyes filled with silicone oil. Graefes Arch. Clin. Exp. Ophthalmol. 240, 829\u2013834 (2002).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"1500_CR16","first-page":"1986","volume":"43","author":"DS McLeod","year":"2002","unstructured":"McLeod, D. S. et al. Quantifying changes in RPE and choriocapillaris in eyes with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 43, 1986\u20131993 (2002).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"1500_CR17","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1167\/iovs.09-3639","volume":"50","author":"DS McLeod","year":"2009","unstructured":"McLeod, D. S. et al. Relationship between RPE and choriocapillaris in age-related macular degeneration. Investig. Ophthalmol. Vis Sci. 50, 4982\u20134991 (2009).","journal-title":"Investig. Ophthalmol. Vis Sci."},{"key":"1500_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ajpath.2019.04.005","volume":"189","author":"EH Sohn","year":"2019","unstructured":"Sohn, E. H. et al. Choriocapillaris degeneration in geographic atrophy. Am. J. Pathol. 189, 1473\u20131480 (2019).","journal-title":"Am. J. Pathol."},{"key":"1500_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajo.2015.01.022","volume":"159","author":"K Ohno-Matsui","year":"2015","unstructured":"Ohno-Matsui, K. et al. International classification and grading system for myopic maculopathy. Am. J. Ophthalmol. 159, 877\u2013883 (2015).","journal-title":"Am. J. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01500-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01500-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01500-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:06:39Z","timestamp":1670087199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01500-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01500-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Financial Disclosures: All authors: European patent application 16 720 043.5 and US patent application US 2019 0085065 A1: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21908"}}